SARS-CoV-2 Infection

Showing NaN - NaN of 4

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

SARS-CoV-2 Infection, COVID-19 Trial in Worldwide (BNT162b2, Placebo, BNT162b2 OMI)

Recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • +4 more
  • Athens, Alabama
  • +158 more
Jul 18, 2022

Pneumococcal Disease, COVID-19, SARS-CoV-2 Infection Trial in United States (20-valent pneumococcal conjugate vaccine (20vPnC),

Completed
  • Pneumococcal Disease
  • +2 more
  • 20-valent pneumococcal conjugate vaccine (20vPnC)
  • +2 more
  • Anaheim, California
  • +28 more
Mar 23, 2022

SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2, BNT162b2.B.1.351)

Completed
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • BNT162b2.B.1.351
  • Oakland, California
  • +16 more
Feb 17, 2022

SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2)

Completed
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • Anaheim, California
  • +20 more
Feb 17, 2022